Devyser Thalassemia for NGS
Genetic Testing for Thalassemias
Alpha and beta-thalassemia are severe forms of anemia. Alpha-thalassemia is most often caused by deletions in one or both HBA genes, while the major cause of beta-thalassemia is single nucleotide variants (SNVs) in the HBB gene.
Discover the advantages
- One simple assay for all thalassemia genetic testing needs
- Single tube NGS analysis of mutations causing both alpha and beta-thalassemia
- Detects both SNVs and deletions in the HBA1, HBA2 and HBB genes
- Simple, fast and robust NGS workflow – NGS has never been easier
- Optimized data analysis software
One Assay for all Testing Needs
Devyser Thalassemia detects all mutations in HBA1, HBA2 and HBB including SNVs, Indels and CNVs. It is optimized to be used for both large scale mutation screening and advanced second level genetic testing. The fast, simple and robust NGS workflow replaces time consuming multi-step protocols and the need for maintaining several different assays in your lab.
Devyser’s proprietary PCR chemistry provides complete and uniform coverage of the targeted regions. It also enables a high level of overlapping amplicon multiplexing, which results in a unique NGS library preparation process with no sample splitting. This simplifies the workflow, reduces the risk of contamination and minimizes the potential for sample mix-up.
To enable sensitive and reliable detection of known deletions, direct detection using primers aligned to both ends of the breakpoint is implemented for 17 large deletions with high prevalence. Simultaneously, sequence-coverage based CNV analysis confirms the detected deletions and identifies other deletions in the targeted region.
Data Analysis
Laboratories have a choice of tailored analytical software solutions, locally deployed or cloud-based.
Devyser Thalassemia for NGS
Genetic Testing for Thalassemias
Alpha and beta-thalassemia are severe forms of anemia. Alpha-thalassemia is most often caused by deletions in one or both HBA genes, while the major cause of beta-thalassemia is single nucleotide variants (SNVs) in the HBB gene.
Discover the advantages
- One simple assay for all thalassemia genetic testing needs
- Single tube NGS analysis of mutations causing both alpha and beta-thalassemia
- Detects both SNVs and deletions in the HBA1, HBA2 and HBB genes
- Simple, fast and robust NGS workflow – NGS has never been easier
- Optimized data analysis software
One Assay for all Testing Needs
Devyser Thalassemia detects all mutations in HBA1, HBA2 and HBB including SNVs, Indels and CNVs. It is optimized to be used for both large scale mutation screening and advanced second level genetic testing. The fast, simple and robust NGS workflow replaces time consuming multi-step protocols and the need for maintaining several different assays in your lab.
Devyser’s proprietary PCR chemistry provides complete and uniform coverage of the targeted regions. It also enables a high level of overlapping amplicon multiplexing, which results in a unique NGS library preparation process with no sample splitting. This simplifies the workflow, reduces the risk of contamination and minimizes the potential for sample mix-up.
To enable sensitive and reliable detection of known deletions, direct detection using primers aligned to both ends of the breakpoint is implemented for 17 large deletions with high prevalence. Simultaneously, sequence-coverage based CNV analysis confirms the detected deletions and identifies other deletions in the targeted region.
Data Analysis
Laboratories have a choice of tailored analytical software solutions, locally deployed or cloud-based.
- Downloads
- Product details
IFU and software settings
Enter access code found in the lower right corner of the label on the kit box.
Certificates
Download a specific Batch Release Certificate (BRC) below by entering the BATCH/LOT number and then click on "Find".
Product details
Research Use Only Kits
Ask Us a Question
We are specialists when it comes to diagnostic kits for complex DNA testing within oncology, reproductive health and hereditary diseases. Our products are used to guide targeted cancer therapies, to enable rapid prenatal diagnostics, as well as in a wide array of genetic tests. Routine diagnostic laboratories in more than 50 countries worldwide use our products.